Leibniz ScienceCampus Chronic Inflammation

Arthritis, multiple sclerosis, colitis or type 2 diabetes: Millions of people in Germany suffer from chronic inflammatory diseases. Those affected have permanent complaints of the joints, skin, kidneys, nervous system or intestines – actually any organ can be affected.

The patients are severely limited in their daily lives. Sometimes these diseases can even be fatal. Modern therapies have so far only helped to suppress the symptoms. They usually cannot cure the disease itself.

This is exactly what the Leibniz ScienceCampus Berlin wants to change. Physicians and scientists from various specialties such as rheumatology, gastroenterology, nephrology, neuropathology and dermatology work together at the Charité and the DRFZ. They investigate and compare the causes and mechanisms of chronic inflammatory diseases.

They pursue several long-term goals. If a disease has already been successfully treated, the therapy should be transferred more quickly to other diseases and thus help more patients. In addition, therapies should be optimally adapted and chronic inflammations may even be cured.

Since 2020, Chiara Romagnani is Professor of Immunology with a focus on inflammation, and head of the Leibniz ScienceCampus Chronic Inflammation.

“We believe by combining our unique scientific expertise and high innovative technologies with excellent clinical partnerships, we can move the field forward and have a real impact for patient care.”

Click here for the full interview.